People

Prosonix has announced the appointment of Geoff Down to the newly-created position of Chief Medical Officer, effective immediately. Down, who has extensive experience in clinical development and has served various roles, some as a consultant pharmaceutical physician, for Pfizer, Respivert, GSK, and other companies, will oversee clinical development of the Pronsonix … [Read more...] about Prosonix appoints Geoff Down as Chief Medical Officer

Team Consulting has announced two new hires: Mark Shepherd, formerly Physical Properties Scientist in respiratory product development at GSK, and Human Factors and User Research Consultant Ben Cox. Shepherd, who has experience with dry powder and intranasal compounds, will be responsible for laboratory quality systems and procedures. “Having spent many years … [Read more...] about Mark Shepherd, Ben Cox join Team Consulting

SkyePharma CEO Axel Mueller has resigned "to pursue other interests," according to the company, and will be replaced by current Chief Financial Officer Peter Grant. The company's announcement says that Grant, who has been CFO since 2006, "will retain responsibility for the Group's financial matters and will oversee the continuing activities to achieve Flutiform … [Read more...] about Skye Pharma CEO Axel Mueller resigns

Contract research organization Melbourn Scientific has announced the promotion of Derek Solomon to Operations Director, effective immediately. Solomon, who joined the company in 2005, previously held the title of Laboratory Manager and oversaw Melbourn's addition of formulation development and clinical manufacture to its services. Melbourn CEO Mark Hammond … [Read more...] about Melbourn Scientific promotes Derek Solomon

As UK-based Prosonix transitions from a particle engineering specialist into a pharmaceutical company with three inhaled respiratory drugs in its pipeline, it has announced the appointment of Rob Crocker as its first Head of Regulatory Affairs. Crocker, who has overseen marketing applications for a number of inhaled and nasal drug products as Managing Director of the … [Read more...] about Prosonix appoints Rob Crocker as Head of Regulatory Affairs

MAP Pharmaceuticals has appointed W. James O'Shea, a former President and COO of Sepracor, to its board of directors. During eight years at Sepracor, O'Shea held a number of positions in operations and commercialization and had previously worked for Zeneca Pharmaceuticals, including as Senior VP of Sales and Marketing and Medical Affairs. MAP is preparing for the … [Read more...] about MAP adds James O’Shea to board of directors

UK dry powder dispensing company VaryDose has announced the appointment of Philippe Rogueda as its Chief Technology Officer. According to the company, "Philippe brings with him many years’ experience and expertise in the powder handling and pharmaceutical formulation industry. Philippe is an industry renowned product development specialist with extensive experience of … [Read more...] about VaryDose appoints Philippe Rogueda as CTO

The prize for the best poster presented at PowderFlow 2011 was awarded to Hanne Kinnunen, a PhD student in the Pharmaceutical Surface Science Research Group, Department of Pharmacy and Pharmacology at the University of Bath, for her poster titled, "The impact of loaded drug dose and the surface roughness of the coarse lactose carrier to the fluidisation … [Read more...] about Powder Flow 2011 poster prize awarded to Hanne Kinnunen